Clinical trial
Triamcinolone vs. Laser for Diabetic Macular Edema
NCT00229931 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00229931 |
|---|---|
| Title | Triamcinolone vs. Laser for Diabetic Macular Edema |
| Official title | The Role of Triamcinolone Injection During Cataract Extraction for Diabetic Patients With Pre-Operative Macular Edema |
| Acronym | IVTA |
| Lead sponsor | University of Oklahoma, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | DIABETIC MACULAR EDEMA |
| Intervention type | Drug, Procedure |
| Interventions | Triamcinolone acetonide, laser |
| Enrollment | 11 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Sep 30, 2005 |
| Last update posted | Dec 28, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: